INEXPLICABLE IMMUNOLOGY? NEW-ONSET RHEUMATOID ARTHRITIS IN A RENAL TRANSPLANT PATIENT ON TRIPLE IMMUNOSUPPRESSIVE THERAPY

被引:0
|
作者
Tugnet, Nicola [1 ]
Dixey, Josh [1 ]
机构
[1] Royal Wolverhampton Hosp NHS Trust, Wolverhampton, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [41] Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population
    Crane, Martin M.
    Juneja, Maneesh
    Allen, Jeffery
    Kurrasch, Regina H.
    Chu, Myron E.
    Quattrocchi, Emilia
    Manson, Stephanie C.
    Chang, David J.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (12) : 1646 - 1655
  • [42] New-Onset Collagenous Colitis in a Patient With Psoriatic Arthritis: Can It Be Secukinumab?
    Obeidat, Adham E.
    Murakami, Traci T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [43] THERAPY OF RHEUMATOID-ARTHRITIS WITH CYCLOSPORIN-A, A NEW IMMUNOSUPPRESSIVE DRUG
    HERRMANN, B
    MULLER, W
    AKTUELLE RHEUMATOLOGIE, 1979, 4 (03) : 173 - 186
  • [44] Late-onset posttransplant lymphoproliferative disease in a male kidney transplant patient on minimal triple immunosuppressive therapy: Diagnosis and management
    Anupama, Sneha Haridas
    Mathew, Milly
    Bandolo, Victorine
    Koshy, Priyanka
    Abraham, Georgi
    INDIAN JOURNAL OF TRANSPLANTATION, 2019, 13 (02) : 141 - 144
  • [45] New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab
    Toussirot, Eric
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1230 - 1231
  • [46] Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
    Liu, Fu-Chao
    Lin, Huan-Tang
    Lin, Jr-Rung
    Yu, Huang-Ping
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1043 - 1051
  • [47] Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis
    Asha Krishnan
    Derrick J. Stobaugh
    Parakkal Deepak
    Rheumatology International, 2015, 35 : 661 - 668
  • [48] Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy
    Leipe, Jan
    Christ, Lisa A.
    Arnoldi, Andreas P.
    Mille, Erik
    Berger, Frank
    Heppt, Markus
    Goldscheider, Ilana
    Kauffmann-Guerrero, Diego
    Huber, Rudolf M.
    Dechant, Claudia
    Berking, Carola
    Schulze-Koops, Hendrik
    Skapenko, Alla
    RMD OPEN, 2018, 4 (02):
  • [49] Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis
    Krishnan, Asha
    Stobaugh, Derrick J.
    Deepak, Parakkal
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (04) : 661 - 668
  • [50] New-Onset Diabetes After Transplant in a Sudanese Renal Transplant Population: Prevalence and Risk Factors
    Ahmed, Ihab Abdel-Rahim Mohamed
    Osman, Rafaa K. H.
    Khalifa, Nazik O.
    Ismail, Manal Omar
    Musa, Tayeb A.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (06) : 627 - 630